We are live on ! Find out more
CA

Cullinan Associates Portfolio holdings

AUM $1.24B
1-Year Est. Return 28.12%
This Fund
S&P 500
This Quarter Est. Return
+1.81%
1 Year Est. Return
+28.12%
3 Year Est. Return
+86.66%
5 Year Est. Return
+111.98%
10 Year Est. Return
+372.59%
AUM
$1.17B
AUM Growth
+$4.34M
Cap. Flow
-$6.31M
Cap. Flow %
-0.54%
Top 10 Hldgs %
39.26%
Holding
205
New
5
Increased
76
Reduced
80
Closed
8

Top Buys

Rank Stock Value
1
JD icon
JD.com
JD
+$2.61M
2
SNY icon
Sanofi
SNY
+$2.39M
3
BMY icon
Bristol-Myers Squibb
BMY
+$2.28M
4
TPR icon
Tapestry
TPR
+$2.23M
5
PM icon
Philip Morris
PM
+$1.86M

Top Sells

Rank Stock Value
1
AFL icon
Aflac
AFL
+$9.87M
2
ABBV icon
AbbVie
ABBV
+$5.53M
3
VMC icon
Vulcan Materials
VMC
+$2.25M
4
UPS icon
United Parcel Service
UPS
+$1.98M
5
YUM icon
Yum! Brands
YUM
+$1.69M

Sector Composition

Rank Sector Weight
1 Consumer Staples 31.19%
2 Financials 11.71%
3 Healthcare 11.11%
4 Technology 10.83%
5 Industrials 9.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DIS icon
26
Walt Disney
DIS
$165B
$10.3M 0.88%
98,846
+2,680
+3% +$261K
AMGN icon
27
Amgen
AMGN
$203B
$9.98M 0.85%
68,229
-1,376
-2% -$207K
PFE icon
28
Pfizer
PFE
$140B
$9.95M 0.85%
322,928
-23,367
-7% -$713K
WFC icon
29
Wells Fargo
WFC
$261B
$9.71M 0.83%
176,151
-1,549
-0.9% -$77.9K
TXN icon
30
Texas Instruments
TXN
$255B
$9.25M 0.79%
126,776
+501
+0.4% +$35.8K
VRTX icon
31
Vertex Pharmaceuticals
VRTX
$121B
$9.22M 0.79%
125,210
-2,800
-2% -$228K
AFL icon
32
Aflac
AFL
$63.9B
$9.1M 0.77%
261,400
-280,200
-52% -$9.87M
SPY icon
33
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$8.74M 0.74%
39,108
+65
+0.2% +$14.2K
MXIM
34
DELISTED
Maxim Integrated Products
MXIM
$8.55M 0.73%
221,601
+3,801
+2% +$149K
LOW icon
35
Lowe's Companies
LOW
$116B
$8.41M 0.72%
118,262
-18,860
-14% -$1.33M
JD icon
36
JD.com
JD
$40.8B
$8.39M 0.72%
330,000
+100,000
+43% +$2.61M
VFC icon
37
VF Corp
VFC
$6.68B
$8.1M 0.69%
161,179
+6,069
+4% +$315K
DE icon
38
Deere & Co
DE
$170B
$8.01M 0.68%
77,730
-4,190
-5% -$394K
MON
39
DELISTED
Monsanto Co
MON
$8M 0.68%
76,000
-1,310
-2% -$134K
MDT icon
40
Medtronic
MDT
$107B
$7.87M 0.67%
110,473
+1,777
+2% +$140K
BMY icon
41
Bristol-Myers Squibb
BMY
$127B
$7.65M 0.65%
130,868
+41,772
+47% +$2.28M
MO icon
42
Altria Group
MO
$122B
$7.43M 0.63%
109,845
+20,245
+23% +$1.3M
COF icon
43
Capital One
COF
$124B
$7.42M 0.63%
84,995
-5,735
-6% -$462K
HD icon
44
Home Depot
HD
$332B
$7.29M 0.62%
54,350
+5,150
+10% +$664K
OXY icon
45
Occidental Petroleum
OXY
$57B
$7.12M 0.61%
99,960
+8,695
+10% +$618K
CELG
46
DELISTED
Celgene Corp
CELG
$7.11M 0.61%
61,418
-647
-1% -$72.1K
PLD icon
47
Prologis
PLD
$138B
$7.07M 0.6%
133,900
-800
-0.6% -$40.7K
ORCL icon
48
Oracle
ORCL
$331B
$6.89M 0.59%
179,200
+11,300
+7% +$442K
T icon
49
AT&T
T
$165B
$6.76M 0.58%
210,595
+10,139
+5% +$299K
PSX icon
50
Phillips 66
PSX
$82.9B
$6.57M 0.56%
76,084
+14,947
+24% +$1.24M
1
2
3 4 5

Similar funds

WTA
Washington Trust Advisors Wellesley, Massachusetts $1.24B AUM 22.58% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
GX
Greylock XIV Menlo Park, California $1.24B AUM
HCA
Harbor Capital Advisors Chicago, Illinois $1.23B AUM 30.56% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
CCA
Clearwater Capital Advisors Hoffman Estates, Illinois $1.24B AUM 15.23% 1-Year Est. Return
FLII
First Long Island Investors Jericho, New York $1.23B AUM 14.42% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Cullinan Associates's Q4 2016 Portfolio in Review

As of Q4 2016, Cullinan Associates held 205 positions worth $1.17B, up 0.37% from $1.17B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Cullinan Associates's Q4 2016 filing shows 5 new, 76 increased, 80 reduced and 8 closed positions. Its largest new stake was Sanofi: 60,660 shares worth $2.45M. The largest sale was Aflac, an estimated $9.87M.

By sector, the portfolio is most concentrated in Consumer Staples at 31% of assets, down from 32% a quarter earlier, followed by Financials and Healthcare.

  • Cullinan Associates's largest Q4 2016 buy was Sanofi: 60,660 shares worth $2.45M.
  • Cullinan Associates added most to JD.com in Q4 2016, an estimated $2.61M increase.
  • Cullinan Associates's biggest Q4 2016 reduction was Aflac, cutting an estimated $9.87M.
  • Cullinan Associates fully exited Vulcan Materials in Q4 2016, selling an estimated $2.25M.
  • Cullinan Associates's ten largest holdings make up 39% of its $1.17B portfolio in Q4 2016.
  • Cullinan Associates opened 5 new positions and closed 8 in Q4 2016.
  • Cullinan Associates's portfolio value rose 0.37% quarter-over-quarter to $1.17B.

Based on Cullinan Associates's 13F filing for Q4 2016, filed 30 Jan 2017.